Potential Risk Factors for Stroke
Carotid Atherosclerosis, Cerebrovascular Accident, Diabetes Mellitus
About this trial
This is an interventional treatment trial for Carotid Atherosclerosis focused on measuring Cerebral Ischemia, Hypertension, Immune Response, Carotid Stenosis, Atherosclerosis
Eligibility Criteria
Male or female greater than 18 years of age. Patient must have documented hypertension (diastolic BP greater than 90 mmHg or systolic BP greater than 140 mmHg) for greater than 1 year OR hypercholesterolemia (LDL greater than 160 or total Chol greater than 240 with a total cholesterol/HDL-Chol ratio more than 1.6 for greater that 1 year OR Diabetes (blood glucose greater than 150 mg/dl requiring oral antihyperglycemics or insulin dependent) for greater than 1 year OR any combination. Subgroup eligibility for risk factors with cerebral ischemic events must meet criteria #2 plus documented stroke by physical exam and CT and/or MRI consistent with ischemic infarction or TIA witnessed and recorded by medical personnel. Patient will be excluded if enrollment time is within 30 days of a stroke, myocardial infarction, or surgery. Patient may be enrolled after 30 days of the above events. No patients on immunosuppressive therapy. No patients who are unable to follow up for 1 year from the time of enrollment. No stroke patients with an identifiable cardiac source (including atrial fibrillation, mural thrombus, valvular disease with vegetation).
Sites / Locations
- National Institute of Neurological Disorders and Stroke (NINDS)